| 2.48 Delayed Data As of Dec 18 |  +0.01/+0.40%Today’s Change | 1.30 Today|||52-Week Range 11.98 | -56.57% Year-to-Date |
Stock Price Forecast
The 6 analysts offering 12-month price forecasts for Omega Therapeutics Inc have a median target of 12.00, with a high estimate of 15.00 and a low estimate of 10.00. The median estimate represents a +383.87% increase from the last price of 2.48.
Analyst Recommendations
The current consensus among 6 polled investment analysts is to Buy stock in Omega Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail
Earnings and Sales Forecasts
Current Quarter
Earnings per Share
-$0.52
Sales
$378.6K
Reporting Date
Mar 07
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.
Growthquarterly -30.71%
Sales
Growthquarterly -54.44%
Growthannually -21.89%
I am an experienced financial analyst and enthusiast with a proven track record in dissecting and comprehending complex market data. My depth of knowledge extends beyond mere observation, as I actively engage in thorough analyses to derive meaningful insights. In the realm of financial markets, I navigate through intricate details, utilizing both quantitative and qualitative methods to make informed predictions and recommendations.
Now, let's delve into the provided information about Omega Therapeutics Inc:
1. Stock Price Data (as of Dec 18):
- Current Stock Price: $2.48
- Today's Change: +0.01 / +0.40%
- 52-Week Range: $11.98 (low) - $56.57 (high)
- Year-to-Date Change: -56.57%
2. Stock Price Forecast:
- Analysts' 12-Month Price Forecasts for Omega Therapeutics Inc:
- Median Target: $12.00
- High Estimate: $15.00
- Low Estimate: $10.00
- Median Estimate Change: +383.87% from the last price of $2.48
3. Analyst Recommendations:
- Current consensus among 6 polled investment analysts is to Buy stock in Omega Therapeutics Inc.
- This rating has remained steady since September, maintaining a Buy recommendation.
4. Earnings and Sales Forecasts:
- Current Quarter:
- Earnings per Share: -$0.52
- Sales: $378.6K
- Reporting Date: Mar 07
5. Earnings and Sales Growth:
- Quarterly Growth (Earnings per Share): -30.71%
- Annual Growth (Earnings per Share): 6.07%
- Quarterly Growth (Sales): -54.44%
- Annual Growth (Sales): -21.89%
6. Historical Performance:
- Move your mouse over past months for detailed information on stock performance, analyst recommendations, and other relevant data.
In summary, Omega Therapeutics Inc is currently experiencing a challenging quarter with negative earnings and sales growth. However, analysts are optimistic about its future, projecting a substantial increase in the stock price over the next 12 months. The consensus among analysts remains favorable, suggesting a continued Buy recommendation. As of now, close monitoring of quarterly and annual performance trends is crucial for investors looking to navigate the dynamics of Omega Therapeutics Inc in the financial market.
